UiPath tumbled after it cited uncertainty over U.S. government spending. as a reason for a disappointing revenue outlook.
Cooler February inflation doesn’t mean Fed will lower rates, promising obesity drug could challenge Novo Nordisk and Eli ...
Incoming Intel CEO Lip-Bu Tan brings "instant credibility" that should help restore investor confidence and support the ...
Chinese markets led the decline as investors watched for the next steps in President Donald Trump’s trade war. Hong Kong's ...
The chip maker is currently trading at 23.3 times earnings expected over the next 12 months, which is below its five-year ...
Asian shares were mostly lower on Thursday despite a rebound on Wall Street fuelled by an encouraging update on US consumer ...
Goldman Sachs analysts called the big US tech stocks the “Maleficent 7” instead of “Magnificent 7” as they slashed their ...
Oracle’s cloud may be been in the running to be the host of a massive AI training system for Elon Musk’s xAI startup, with a ...
Arya maintained a buy rating on Nvidia's stock, with a price target of $200. He believes the company can maintain an 80% to 85% share of the market for AI server chips, despite increased competition ...
In the bond market, Treasury yields climbed to regain more of their losses from recent months sparked by worries about the ...
In the bond market, Treasury yields edged up to regain more of their losses from recent months sparked by worries about the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results